LineaRx Anticipates Expansion in Diagnostics Market
May 21st, 2019
Tag: LinearDNA
LineaRx Achieves Higher Expression and Survival Rates in Human T Cells
April 29th, 2019
Linear DNA Crosses the Line between Tags and Therapeutics
April 9th, 2019
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8th, 2019
Applied DNA Subsidiary LineaRx and Takis/Evvivax Progress Linear DNA for Use as Cancer Vaccine Candidates
March 1st, 2019
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4th, 2018
LineaRx Provides Cost and Quality Advantages to Technogenetics
November 7th, 2018
At LineaRX, Putting The Horsepower Behind The CAR T
October 17th, 2018
Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
October 16th, 2018